BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kmira Z, Nesrine BS, Houneida Z, Wafa BF, Aida S, Yosra BY, Monia Z, Sriha B, Abderrahim K. Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use. World J Gastrointest Pathophysiol 2013; 4(3): 59-62 [PMID: 23946889 DOI: 10.4291/wjgp.v4.i3.59]
URL: https://www.wjgnet.com/2150-5330/full/v4/i3/59.htm
Number Citing Articles
1
Jae-Ki Choi, Sung-Yeon Cho, Su-Mi Choi, Gyo Hui Kim, Sung-Eun Lee, Seok Lee, Dong-Wook Kim, Dong-Gun Lee. Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature ReviewInfection & Chemotherapy 2018; 50(2): 153 doi: 10.3947/ic.2018.50.2.153
2
Gabriella Mezei, Ildiko Beke Debreceni, Adrienne Kerenyi, Gyula Remenyi, Robert Szasz, Arpad Illes, Janos Kappelmayer, Peter Batar. Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemiaPlatelets 2019; 30(7): 836 doi: 10.1080/09537104.2018.1501470
3
Arborea Graziana, Valentini Anna Maria, Marangi Stefania, LT Nicoletta Labarile, Savino Maria Teresa. Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literatureInternational Journal of Pharmaceutical Sciences and Developmental Research 2023; 9(1): 006 doi: 10.17352/ijpsdr.000046
4
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020;  doi: 10.1017/9781316823026
5
Moaath K. Mustafa Ali, Marwa M. Sabha, Kamal H. Al-Rabi. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatmentPlatelets 2015; 26(5): 491 doi: 10.3109/09537104.2014.935316
6
Mohamed A. Yassin, Abdulqadir J. Nashwan, Ashraf T Soliman, Anil Yousif, Afra Moustafa, Afaf AlBattah, Shehab F. Mohamed, Deena S. Mudawi, Sarah Elkourashy, Deena-Raiza Asaari, Hope-Love G. Gutierrez, Mohamed Almusharaf, Radwa M. Hussein, Abbas H. Moustafa, Hatim El Derhoubi, Sarra Boukhris, Samah Kohla, Nader AlDewik. Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront TherapyClinical Medicine Insights: Case Reports 2015; 8: CCRep.S25327 doi: 10.4137/CCRep.S25327
7
Leonardo Campiotti, Elena Bolzacchini, Matteo Basilio Sutter, Andrea Maria Maresca, Anna Maria Grandi, Luigina Guasti. Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemiaInternal and Emergency Medicine 2018; 13(8): 1337 doi: 10.1007/s11739-018-1957-0
8
Aoife McCarthy, Kieran Sheahan. Non-Neoplastic Pathology of the Gastrointestinal Tract2020; : 65 doi: 10.1017/9781316823026.006
9
Naoki Oshima, Yoshiyuki Mishima, Kotaro Shibagaki, Kousaku Kawashima, Norihisa Ishimura, Fumiyoshi Ikejiri, Chie Onishi, Takahiro Okada, Masaya Inoue, Ichiro Moriyama, Junji Suzumiya, Yoshikazu Kinoshita, Shunji Ishihara. Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case reportBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-020-01584-6
10
Leonardo Bautista Toloza, Humberto Martínez, Orlando Bonell Patiño. Hematoma intraparenquimatoso del sistema nervioso central asociado con dasatinib en el tratamiento de leucemia mieloide crónica en fase acelerada. Presentación de dos casos y revisión de la literaturaRevista Colombiana de Cancerología 2018; 22(4): 151 doi: 10.1016/j.rccan.2017.10.002
11
Eunjung Yim, Yeon-Geun Choi, Yoon-Jeong Nam, Jain Lee, Jeong-A Kim. Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemiaThe Korean Journal of Internal Medicine 2018; 33(2): 446 doi: 10.3904/kjim.2015.325
12
Seyyed Javad Boskabadi, Ayat Dashti, Sara Karevan, Saeed Kargar-Soleimanabad, Ebrahim Salehifar. Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative reviewJournal of Oncology Pharmacy Practice 2023; : 107815522311747 doi: 10.1177/10781552231174790
13
Jeong Min Kim, Hyun Mi Kang, In Hyuk Yoo, Dong-Gun Lee, Nack-Gyun Chung, Bin Cho. Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation RecipientsPediatric Gastroenterology, Hepatology & Nutrition 2023; 26(4): 224 doi: 10.5223/pghn.2023.26.4.224
14
Amlan Kusum Datta, Partha Debnath, Uddalak Chakraborty, Atanu Chandra. Clostridioides difficile-induced diarrhoea following dasatinib therapyBMJ Case Reports 2021; 14(1): e239394 doi: 10.1136/bcr-2020-239394
15
John B. Bossaer, Stephen A. Geraci, Kanishka Chakraborty. Cardiovascular Toxicity and Management of Targeted Cancer TherapyThe American Journal of the Medical Sciences 2016; 351(5): 535 doi: 10.1016/j.amjms.2016.02.023
16
Mohamed Shanshal, Andrew Shakespeare, Seshadri Thirumala, Boyd Fenton, Donald P. Quick. Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the LiteratureActa Haematologica 2016; 136(4): 219 doi: 10.1159/000448983
17
Ibrahim Aldoss, Karl Gaal, Monzr M. Al Malki, Haris Ali, Ryotaro Nakamura, Stephen J. Forman, Vinod Pullarkat. Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaBiology of Blood and Marrow Transplantation 2016; 22(10): 1900 doi: 10.1016/j.bbmt.2016.06.022
18
Güray Can, Süleyman Ayvaz, Hatice Can, İhsan Karaboğa, Selim Demirtaş, Hasan Akşit, Bülent Yılmaz, Uğur Korkmaz, Mevlüt Kurt, Turan Karaca. The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitisClinics and Research in Hepatology and Gastroenterology 2016; 40(4): 504 doi: 10.1016/j.clinre.2015.12.006
19
Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, Yasuhiko Harada, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura. Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patientsBlood 2017; 129(1): 126 doi: 10.1182/blood-2016-08-734947